Lithium carbonate

CAS No. 554-13-2

Lithium carbonate( —— )

Catalog No. M21193 CAS No. 554-13-2

Lithium carbonate is an effective drug against bipolar disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lithium carbonate
  • Note
    Research use only, not for human use.
  • Brief Description
    Lithium carbonate is an effective drug against bipolar disorders.
  • Description
    Lithium carbonate is an effective drug against bipolar disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    Cardiovascular Disease
  • Indication
    Spinocerebellar Ataxia Type 3Machado Joseph Disease

Chemical Information

  • CAS Number
    554-13-2
  • Formula Weight
    73.9
  • Molecular Formula
    CLi2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C([O-])[O-].[Li+].[Li+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Geeva Shoba N . Lithium entrapped chitosan nanoparticles to reduce toxicity and increase cellular uptake of lithium[J]. Environmental Toxicology & Pharmacology 2018 61:79-86.
molnova catalog
related products
  • Grossamide

    Grossamide possesses potential anti-inflammatory effects, it also has potential anti-neuroinflammatory effects against lipopolysaccharide (LPS)-induced inflammatory response in BV2 microglia cells. Cis-Grossamide K exerts a particularly strong anti-melanogenic activity on the cells without high cell toxicity.

  • Benzamide, N-(3-imid...

    Benzamide, N-(3-imidazo[2,1-b]thiazol-6-ylphenyl)-2-methoxy exhibits antidiabetic, anti-inflammatory and antitumor activities.

  • Galangin

    Galangin is an agonist/antagonist of the arylhydrocarbon receptor, and also shows inhibition of CYP1A1 activity.